Amgen And Advaxis Enter Global Cancer Immunotherapies Collaboration
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St rises as Anthropic's IPO filing sharpens focus on AI trade
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| ADVAXIS (AMEX: ADXS) | Delayed: 0.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.60 | 52 Week High | $16.30 | |||
| Open | $0.60 | 52 Week Low | $5.21 | |||
| Day High | $0.60 | P/E | N/A | |||
| Day Low | $0.60 | EPS | $-4.10 | |||
| Volume | 5,082,866 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 442.99 +3.73 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $439.26 | 52 Week High | $176.85 | |||
| Open | $444.89 | 52 Week Low | $133.64 | |||
| Day High | $449.80 | P/E | 66.72 | |||
| Day Low | $442.28 | EPS | $6.64 | |||
| Volume | 552,417 | |||||
